Shingles: Clinical Trials

5 trials for Shingles, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5
Phase 31Completed 1

Follow Shingles: new trials by email Literature Review of Shingles trials Research Report on Shingles

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Systems Biology of Zoster Vaccine
Shingrix® - Zoster, Zoster Varicella
Phase 2CompletedEmory University382019-11-142024-07-30
A Study of FV-100 Versus Valacyclovir in Patients With Herpes Zoster
valacyclovir, FV-100, Valacyclovir placebo - Herpes Zoster, Shingles
Phase 2CompletedBristol-Myers Squibb3502009-05-012015-10-12
A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)
KD7040 Topical Gel, Placebo gel - Postherpetic Neuralgia, Shingles
Phase 2CompletedKalypsys, Inc.482007-11-012008-07-22
Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007)
zoster vaccine live (Oka/Merck), Comparator: placebo (unspecified) - Shingles
Phase 2CompletedMerck Sharp & Dohme LLC1802001-11-012017-03-15
NGX-4010 for the Treatment of Postherpetic Neuralgia
Capsaicin Dermal Patch - Herpes Zoster, Neuralgia
Phase 2 / Phase 3CompletedNeurogesX3002008-03-06

Narrower conditions

Herpes Zoster (5)  ·  Neuralgia (2)  ·  Chickenpox (1)  ·  Neuralgia, Postherpetic (1)  ·  Pain (1)  ·  Peripheral Nervous System Diseases (1)

Broader conditions

DNA Virus Infections (5)  ·  Herpesviridae Infections (5)  ·  Infections (5)  ·  Varicella Zoster Virus Infection (5)  ·  Virus Diseases (5)  ·  Nervous System Diseases (2)  ·  Neurologic Manifestations (2)  ·  Neuromuscular Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Pain (1)  ·  Peripheral Nervous System Diseases (1)

Interventions

FV-100 (1)  ·  Herpes Zoster Vaccine (1)  ·  Valacyclovir (1)

Sponsors

Bristol-Myers Squibb (1)  ·  Emory University (1)  ·  Kalypsys, Inc. (1)  ·  Merck Sharp & Dohme LLC (1)  ·  NeurogesX (1)

Countries

United States (3)

Top investigators

Nadine Rouphael, MD (1)

Results publications

PMID 22154769, PMID 27943311

NIH funding

U19AI090023 (1)